Company Profile
Established in 1997 in Houston, Texas, Selleckbio has become a leading provider of high-quality chemical reagents and kits for scientific research. Founded by renowned chemist Dr. David Selleck, the company's mission is to empower researchers across diverse fields, including biotechnology, pharmaceuticals, and materials science, with access to cutting-edge products.
Selleckbio's state-of-the-art facilities and expert team of chemists ensure the consistent quality and reliability of its products. The company's extensive portfolio covers a wide range of applications, from biochemistry and cell biology to environmental science, catering to the evolving needs of the research community.
Sustainability is a key focus for Selleckbio, which employs eco-friendly manufacturing processes and sources materials that are safe for the environment. The company's commitment to safety and user-friendliness further enhances its reputation as a trusted partner for researchers worldwide.
Recognized for its innovation and excellence, Selleckbio has earned numerous accolades, including the prestigious Small Business Innovation Research (SBIR) award from the National Institutes of Health (NIH). By continuously pushing the boundaries of chemical research, the company remains at the forefront of the industry, providing researchers with the tools they need to drive scientific progress.
VIEW MORE VIEW LESS
Product List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
3-Pyridinecarboxamide,N-(2,3-dihydro-3,3-dimethyl-1H-indol-6-yl)-2-[(4-pyridinylmethyl)amino]-,phosphate (1:2);Motesanib diphosphate;AMG 706 |
857876-30-3 | Inquiry | ||
2-Pyridinecarboxamide,4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-,4-methylbenzenesulfonate (1:1);2-Pyridinecarboxamide,4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-,mono(4-methylbenzenesulfonate);BAY 43-9006 mono-p-tosylate;Sorafenib tosylate;Nexavar;BAY 54-9085;Sorafenib p-toluenesulfonate |
475207-59-1 | Inquiry | ||
17-DIMETHYLAMINOETHYLAMINO-17-DEMETHOXY-GELDANAMYCIN;17-DIMETHYLAMINOGELDANAMYCIN;Alvespimycin hydrochloride;BMS 826476;KOS 1022;AlvespiMycin hydrochloride(17-DMAG,BMS 826476;17-DMAG HCl (AlvespiMycin);17-DMAG (AlvespiMycin) HCl |
467214-21-7 | Inquiry | ||
4-Quinazolinamine,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-,4-methylbenzenesulfonate (1:2);4-Quinazolinamine,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-,bis(4-methylbenzenesulfonate);Lapatinib ditosylate;GW 572016F;Tykerb |
388082-77-7 | Inquiry | ||
Geldanamycin,17-demethoxy-17-(2-propenylamino)-;2-Azabicyclo[16.3.1]docosane,geldanamycin deriv.;17-Demethoxy-17-(2-propenylamino)geldanamycin;CP 127374;17-(Allylamino)-17-demethoxygeldanamycin;NSC 330507;17-(Allylamino)geldanamycin;17-Demethoxy-17-allylaminogeldanamycin;17AAG;KOS 953;Tanespimycin;17-(Allylamino)-17-desmethylgeldanamycin;BMS 722782;17-N-Allylamino-17-demethoxygeldanamycin;17-Allylaminodemethoxygeldanamycin;A 8476 |
75747-14-7 | Inquiry | ||
1,4,5,6,8-Pentaazaacenaphthylen-3-amine,1,5-dihydro-5-methyl-1-β-D-ribofuranosyl-;1,5-Dihydro-5-methyl-1-β-D-ribofuranosyl-1,4,5,6,8-pentaazaacenaphthylen-3-amine;6-Amino-4-methyl-8-(β-D-ribofuranosyl)-4H,8H-pyrrolo[4,3,2-de]pyrimido[4,5-c]pyridazine;NSC 154020;Triciribine;TCN;API 2;AKT Inhibitor V;Triciribidine |
35943-35-2 | Inquiry | ||
ABT 263 |
Benzamide,4-[4-[[2-(4-chlorophenyl)-5,5-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[4-[[(1R)-3-(4-morpholinyl)-1-[(phenylthio)methyl]propyl]amino]-3-[(trifluoromethyl)sulfonyl]phenyl]sulfonyl]-;4-[4-[[2-(4-Chlorophenyl)-5,5-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[4-[[(1R)-3-(4-morpholinyl)-1-[(phenylthio)methyl]propyl]amino]-3-[(trifluoromethyl)sulfonyl]phenyl]sulfonyl]benzamide;ABT 263;Navitoclax;A 855071.0;1000696-69-4 |
923564-51-6 | Inquiry | |
ABT-737 |
Benzamide,4-[4-[(4′-chloro[1,1′-biphenyl]-2-yl)methyl]-1-piperazinyl]-N-[[4-[[(1R)-3-(dimethylamino)-1-[(phenylthio)methyl]propyl]amino]-3-nitrophenyl]sulfonyl]-;4-[4-[(4′-Chloro[1,1′-biphenyl]-2-yl)methyl]-1-piperazinyl]-N-[[4-[[(1R)-3-(dimethylamino)-1-[(phenylthio)methyl]propyl]amino]-3-nitrophenyl]sulfonyl]benzamide;ABT 737 |
852808-04-9 | Inquiry | |
AZD 6244 |
1H-Benzimidazole-6-carboxamide,5-[(4-bromo-2-chlorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-;5-[(4-Bromo-2-chlorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazole-6-carboxamide;ARRY 142886;AZD 6244;Selumetinib;NSC 741O78;G 00039805;6-(4-Bromo-2-chloroanilino)-7-fluoro-N-(2-hydroxyethoxy)-3-methylbenzimidazole-5-carboxamide;Koselugo;AZD6244;AZD-6244;865610-79-3 |
606143-52-6 | Inquiry | |
BIBW 2992 |
2-Butenamide,N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-;N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide;915958-11-1 |
439081-18-2 | Inquiry | |
MK-2206 |
1,2,4-Triazolo[3,4-f][1,6]naphthyridin-3(2H)-one,8-[4-(1-aminocyclobutyl)phenyl]-9-phenyl-,hydrochloride (1:2);MK 2206 dihydrochloride |
1032350-13-2 | Inquiry | |
NVP-BEZ 235 |
Benzeneacetonitrile,4-[2,3-dihydro-3-methyl-2-oxo-8-(3-quinolinyl)-1H-imidazo[4,5-c]quinolin-1-yl]-α,α-dimethyl-;4-[2,3-Dihydro-3-methyl-2-oxo-8-(3-quinolinyl)-1H-imidazo[4,5-c]quinolin-1-yl]-α,α-dimethylbenzeneacetonitrile;2-Methyl-2-[4-[3-methyl-2-oxo-8-(quinolin-3-yl)-2,3-dihydroimidazo[4,5-c]quinolin-1-yl]phenyl]propionitrile;NVP-BEZ 235;BEZ 235;Dactolisib;NVP-BEZ 235NX;NVPBE 235;BEZ 23;RTB 101;2-Methyl-2-[4-[3-methyl-2-oxo-8-(quinolin-3-yl)-1H,2H,3H-imidazo[4,5-c]quinolin-1-yl]phenyl]propanenitrile;2-Methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-ylimidazo[4,5-c]quinolin-1-yl)phenyl]propanenitrile;1146702-52-4 |
915019-65-7 | Inquiry | |
Olaparib |
1(2H)-Phthalazinone,4-[[3-[[4-(cyclopropylcarbonyl)-1-piperazinyl]carbonyl]-4-fluorophenyl]methyl]-;Piperazine,1-(cyclopropylcarbonyl)-4-[5-[(3,4-dihydro-4-oxo-1-phthalazinyl)methyl]-2-fluorobenzoyl]-;4-[[3-[[4-(Cyclopropylcarbonyl)-1-piperazinyl]carbonyl]-4-fluorophenyl]methyl]-1(2H)-phthalazinone;Olaparib;KU 59436;AZD 2281;KU 0059436;4-(3-(4-(Cyclopropanecarbonyl)piperazine-1-carbonyl)-4-fluorobenzyl)phthalazin-1(2H)-one;Lynparza;AZD2281;AZD-2281;937799-91-2;1021843-02-6;894104-70-2 |
763113-22-0 | Inquiry | |
PD 0325901 |
Benzamide,N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-;N-[(2R)-2,3-Dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide;N-[((R)-2,3-Dihydroxypropyl)oxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide;PD 0325901;PD 325901;PD 901;N-[(2R)-2,3-Dihydroxypropoxy]-3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzamide;PD 03525901;Mirdametinib;870474-62-7 |
391210-10-9 | Inquiry | |
Veliparib |
1H-Benzimidazole-7-carboxamide,2-[(2R)-2-methyl-2-pyrrolidinyl]-;1H-Benzimidazole-4-carboxamide,2-[(2R)-2-methyl-2-pyrrolidinyl]-;2-[(2R)-2-Methyl-2-pyrrolidinyl]-1H-benzimidazole-7-carboxamide;A 861695;ABT 888;Veliparib;Veliparib ER;2-[(2R)-2-Methylpyrrolidin-2-yl]-1H-1,3-benzodiazole-4-carboxamide;2-[(2R)-2-Methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide |
912444-00-9 | Inquiry | |
Vismodegib |
Benzamide,2-chloro-N-[4-chloro-3-(2-pyridinyl)phenyl]-4-(methylsulfonyl)-;2-Chloro-N-[4-chloro-3-(2-pyridinyl)phenyl]-4-(methylsulfonyl)benzamide;GDC 0449;Vismodegib;Erivedge |
879085-55-9 | Inquiry |
CONTACT INFORMATION
Sign In for Details